The chair of Wegovy maker Novo Nordisk, Helge Lund, and six other board members are stepping down in a surprise shake-up, after a row with the company’s majority shareholder.
The Danish manufacturer of the blockbuster anti-obesity jab, and the diabetes drug Ozempic, said Lund, the vice-chair, Henrik Poulsen, and five independent board members would quit at an extraordinary meeting on 14 November.
